Suchergebnisse - "Sönnerborg, Anders"

PubPharm (13)

1

Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting : The RESPOND cohort consortium

enthalten in: PloS one | 2020

von Neesgaard, B. | Mocroft, A. | Zangerle, R. | +33

2

Longer-term effectiveness of protease-inhibitor-based second line antiretroviral therapy in four large sub-Saharan African clinics

enthalten in: The Journal of infection | 2019

von Sarfo, F. | Castelnuovo, B. | Fanti, I. | +9

3

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2016

von Hofstra, L. | Sauvageot, N. | Albert, J. | +98

4

Mutational Heterogeneity in p6 Gag Late Assembly (L) Domains in HIV-1 Subtype C Viruses from South Africa

enthalten in: AIDS research and human retroviruses | 2016

von Neogi, U. | Engelbrecht, S. | Claassen, M. | +4

5

Virological failure in patients with HIV-1 subtype C receiving antiretroviral therapy : an analysis of a prospective national cohort in Sweden

enthalten in: The lancet. HIV | 2016

von Häggblom, A. | Svedhem, V. | Singh, K. | +2

CommentIn: Lancet HIV. 2016 Apr;3(4):e149-51. - PMID 27036986

6

Novel tetra-peptide insertion in Gag-p6 ALIX-binding motif in HIV-1 subtype C associated with protease inhibitor failure in Indian patients

enthalten in: AIDS (London, England) | 2014

von Neogi, U. | Rao, S. | Bontell, I. | +12

7

HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failure

enthalten in: Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases | 2013

von Sangeda, R. | Theys, K. | Beheydt, G. | +21

8

Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe

enthalten in: The Journal of infectious diseases | 2013

von De Luca, A. | Dunn, D. | Zazzi, M. | +115

9

Bilirubin-a potential marker of drug exposure in atazanavir-based antiretroviral therapy

enthalten in: The AAPS journal | 2011

von Rekić, D. | Clewe, O. | Röshammar, D. | +6

10

Early virologic rebound in a pilot trial of ritonavir-boosted atazanavir as maintenance monotherapy

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2007

von Karlström, O. | Josephson, F. | Sönnerborg, A.

CommentIn: J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):118; author reply 118-9. - PMID 17909317